For: | Gong XL, Qin SK. Progress in systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol 2016; 22(29): 6582-6594 [PMID: 27547002 DOI: 10.3748/wjg.v22.i29.6582] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i29/6582.htm |
Number | Citing Articles |
1 |
Yuanlong Cao, Yuanyuan Ding, Liping Zhang, Gang Shi, Xinxin Sang, Caihua Ni. Preparation of surface‐modified, micrometer‐sized carboxymethyl chitosan drug‐loaded microspheres. Journal of Applied Polymer Science 2018; 135(4) doi: 10.1002/app.45731
|
2 |
Liang Qin, Cheng-ze Song, Fa-yang Yuan, Xue-fa Wang, Yang Yang, Yi-fei Ma, Zi-li Chen. ELOVL1 is upregulated and promotes tumor growth in hepatocellular carcinoma through regulating PI3K-AKT-mTOR signaling. Heliyon 2024; 10(15): e34961 doi: 10.1016/j.heliyon.2024.e34961
|
3 |
Aneta Rogalska, Barbara Bukowska, Agnieszka Marczak. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells. Toxicology in Vitro 2018; 47: 48 doi: 10.1016/j.tiv.2017.11.001
|
4 |
Yinghua Li, Min Guo, Zhengfang Lin, Mingqi Zhao, Yu Xia, Changbing Wang, Tiantian Xu, Bing Zhu. Multifunctional selenium nanoparticles with Galangin-induced HepG2 cell apoptosis through p38 and AKT signalling pathway. Royal Society Open Science 2018; 5(11): 180509 doi: 10.1098/rsos.180509
|
5 |
Maria Grazia Lucà, Roberto Nani, Melanie Schranz, Massimo De Giorgio, Claudia Iegri, Roberto Agazzi, Francesco Sala, Giorgio Virotta, Donatella Sarti, Grazia Conte, Domenico Pinelli, Carlo Nicora, Michele Colledan, Sandro Sironi, Stefano Fagiuoli. Treatment of Hepatocellular Carcinoma: A Cost Analysis Of Yttrium-90 Transarterial Radioembolization Versus Sorafenib. Future Oncology 2018; 14(8): 727 doi: 10.2217/fon-2017-0566
|
6 |
Camillo Aliberti, Riccardo Carandina, Donatella Sarti, Enrico Pizzirani, Gaetano Ramondo, Umberto Cillo, Stefano Guadagni, Giammaria Fiorentini. Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience. Future Oncology 2017; 13(25): 2243 doi: 10.2217/fon-2017-0364
|
7 |
Mingyu Chen, Jiahao Hu, Jiasheng Cao, Xiujun Cai. Comprehensive Consideration before the Decision-Making of the Systemic Treatment in Patients with Advanced Hepatocellular Carcinoma. Liver Cancer 2020; 9(2): 221 doi: 10.1159/000502775
|
8 |
Lorenza Rimassa, Maria Reig, Giovanni Abbadessa, Markus Peck-Radosavljevic, William Harris, Vittorina Zagonel, Davide Pastorelli, Elena Rota Caremoli, Camillo Porta, Nevena Damjanov, Hitendra Patel, Bruno Daniele, Maria Lamar, Brian Schwartz, Terri Goldberg, Armando Santoro, Jordi Bruix. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(13): 2448-2452 doi: 10.3748/wjg.v23.i13.2448
|
9 |
Liping Zhang, Ming Liu, Tian Qi, Haili Zhou, Caihua Ni. Preparations and properties of drug-eluting embolization microspheres based on modified gelatin. Soft Materials 2018; 16(2): 117 doi: 10.1080/1539445X.2018.1435552
|
10 |
Anna Balasso, Stefano Salmaso, Patrizia Pontisso, Antonio Rosato, Santina Quarta, Alessio Malfanti, Francesca Mastrotto, Paolo Caliceti. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences 2017; 103: 104 doi: 10.1016/j.ejps.2017.02.016
|
11 |
Li Gu, Yahui Zhu, Xi Lin, Xingyu Tan, Bingjun Lu, Youjun Li. Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene 2020; 39(11): 2437 doi: 10.1038/s41388-020-1156-0
|
12 |
Yi-Xia Lou, Jing Gu, Lei Zhu, Sheng-Qi Sun, Xiang-Lin Hao, Jian-Ping Chen, Fei Han, Dan-Dan Wang, Xiao Jiang, Jin-Yi Liu. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway. Laboratory Investigation 2023; 103(12): 100260 doi: 10.1016/j.labinv.2023.100260
|
13 |
Chaojie Liang, Kaitong Zhang, Hua Ge, Wei Li, Guangming Li, Jixiang Wu. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis. Clinica Chimica Acta 2018; 477: 24 doi: 10.1016/j.cca.2017.11.037
|
14 |
Esther Una Cidon. Systemic treatment of hepatocellular carcinoma: Past, present and future. World Journal of Hepatology 2017; 9(18): 797-807 doi: 10.4254/wjh.v9.i18.797
|
15 |
A Galal El-Shemi, A Mohammed Ashshi, E Oh, B-K Jung, M Basalamah, A Alsaegh, C-O Yun. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma. Gene Therapy 2018; 25(1): 54 doi: 10.1038/gt.2017.86
|
16 |
Aneta Rogalska, Arkadiusz Gajek, Małgorzata Łukawska, Irena Oszczapowicz, Agnieszka Marczak, Aamir Ahmad. Novel oxazolinoanthracyclines as tumor cell growth inhibitors—Contribution of autophagy and apoptosis in solid tumor cells death. PLOS ONE 2018; 13(7): e0201296 doi: 10.1371/journal.pone.0201296
|
17 |
Li-Zhu Liao, Chih-Ta Chen, Nien-Chen Li, Liang-Chun Lin, Bo-Shih Huang, Ya-Hui Chang, Lu-Ping Chow. Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2020; 22(1): 224 doi: 10.3390/ijms22010224
|
18 |
Deniz Cansen Kahraman, Ebru Bilget Guven, Peri S. Aytac, Gamze Aykut, Birsen Tozkoparan, Rengul Cetin Atalay. A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17444-0
|
19 |
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
|
20 |
Kazuhiro Takahashi, Krishna G Putchakayala, Mohamed Safwan, Dean Y Kim. Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: A case report. World Journal of Hepatology 2017; 9(22): 973-978 doi: 10.4254/wjh.v9.i22.973
|
21 |
Takuya Sho, Mitsuru Nakanishi, Kenichi Morikawa, Masatsugu Ohara, Naoki Kawagishi, Takaaki Izumi, Machiko Umemura, Jun Ito, Masato Nakai, Goki Suda, Koji Ogawa, Makoto Chuma, Takashi Meguro, Michio Nakamura, Atsushi Nagasaka, Hiromasa Horimoto, Yoshiya Yamamoto, Naoya Sakamoto. A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma. Drugs in R&D 2017; 17(3): 381 doi: 10.1007/s40268-017-0187-7
|
22 |
Nayra Soares do Amaral, Natalia Cruz e Melo, Beatriz De Melo Maia, Rafael Malagoli Rocha. Noncoding RNA Profiles in Tobacco- and Alcohol-Associated Diseases. Genes 2016; 8(1): 6 doi: 10.3390/genes8010006
|
23 |
Ping Sun, Yanlong Li, Lijun Chang, Xudong Tian. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma. Medicine 2019; 98(19): e15603 doi: 10.1097/MD.0000000000015603
|
24 |
Haichao Zhao, Changzhou Chen, Huangqin Song, Rongyi Qin, Xiaoxiao Wang, Qizu He, Feng Li, Haoliang Zhao, Yanjun Li, Md Sayed Ali Sheikh. DNA Topoisomerase II-α Regulated by miR-22-5p Promotes Hepatocellular Carcinoma Invasion and Migration through the Hippo Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/4277254
|
25 |
Xueran Chen, Shangrong Zhang, Zhen Wang, Fengsong Wang, Xinwang Cao, Quan Wu, Chenggang Zhao, Huihui Ma, Fang Ye, Hongzhi Wang, Zhiyou Fang. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0787-2
|
26 |
Shaozhen Xing, Yumin Zhu, Yaxian You, Siqi Wang, Hongke Wang, Meng Ning, Heyue Jin, Zhengxia Liu, Xinhua Zhang, Chunzhao Yu, Zhi John Lu. Cell‐free RNA for the liquid biopsy of gastrointestinal cancer. WIREs RNA 2023; 14(5) doi: 10.1002/wrna.1791
|
27 |
Yuanmin Pei, Xueling Sun, Xiwei Guo, Huashan Yin, Le Wang, Fugu Tian, Hongxi Jing, Xiaobo Liang, Jun Xu, Pengcheng Shi. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells. Oncology Reports 2017; 38(4): 2205 doi: 10.3892/or.2017.5887
|
28 |
Shaoying Ke, Congren Wang, Zijian Su, Shaoze Lin, Gongle Wu. Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.897683
|
29 |
Min Xu, Zhongwei Zhao, Jingjing Song, Xilin Lan, Siming Lu, Minjiang Chen, Zufei Wang, Weiqian Chen, Xiaoxi Fan, Fazong Wu, Li Chen, Jianfei Tu, Jiansong Ji. Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer. Experimental Cell Research 2017; 351(2): 142 doi: 10.1016/j.yexcr.2017.01.008
|
30 |
Rong‑Quan He, Xia Yang, Liang Liang, Gang Chen, Jie Ma. MicroRNA‑124‑3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. Oncology Letters 2018; doi: 10.3892/ol.2018.8045
|
31 |
Xiao-Fei Zhang, Ji Wang, Hu-Liang Jia, Wen-Wei Zhu, Lu Lu, Qing-Hai Ye, Peter J. Nelson, Yi Qin, Dong-Mei Gao, Hai-Jun Zhou, Lun-Xiu Qin. Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma. Cell Death Discovery 2019; 5(1) doi: 10.1038/s41420-019-0164-8
|
32 |
Na Zhan, Adeola Adebayo Michael, Kaiyuan Wu, Gang Zeng, Aaron Bell, Junyan Tao, Satdarshan P. Monga. The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse Model. Gene Expression 2018; 18(2): 135 doi: 10.3727/105221618X15174108894682
|
33 |
Chao Wang, Xin Luo, Shui-Lin Dong, Chao Leng, Bi-Xiang Zhang, Bin-Hao Zhang. Small hepatocellular carcinoma suppressed by chemotherapy for synchronous gastric carcinoma after laparoscopy-assisted radical distal gastrectomy. Medicine 2018; 97(50): e13190 doi: 10.1097/MD.0000000000013190
|
34 |
Liheng Li, Ke He, Siliang Chen, Wenjiang Wei, Zuofu Tian, Yinghong Tang, Chengjiang Xiao, Guoan Xiang. Circ_0001175 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Regulating miR-130a-5p. OncoTargets and Therapy 2020; : 13315 doi: 10.2147/OTT.S262408
|
35 |
Yanxia Gong, Jie Zhang, Xiang Wu, Tao Wang, Jia Zhao, Zhi Yao, Qingyu Zhang, Xi Liu, Xu Jian. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy. Oncology Letters 2017; 14(4): 4158 doi: 10.3892/ol.2017.6724
|